Sex differences in achieving guideline-recommended heart rate control among a large sample of patients at risk for sudden cardiac arrest
- PMID: 38840767
- PMCID: PMC11148490
- DOI: 10.1016/j.hroo.2024.04.008
Sex differences in achieving guideline-recommended heart rate control among a large sample of patients at risk for sudden cardiac arrest
Abstract
Background: Despite known clinical benefits, guideline-recommended heart rate (HR) control is not achieved for a significant proportion of patients with HF with reduced ejection fraction. The wearable cardioverter-defibrillator (WCD) provides continuous HR monitoring and alerts that could aid medication titration.
Objective: This study sought to evaluate sex differences in achieving guideline-recommended HR control during a period of WCD use.
Methods: Data from patients fitted with a WCD from 2015 to 2018 were obtained from the manufacturer's database (ZOLL). The proportion of patients with adequate nighttime resting HR control at the beginning of use (BOU) and at the end of use (EOU) were compared by sex. Adequate HR control was defined as having a nighttime median HR <70 beats/min.
Results: A total of 21,440 women and a comparative sample of 17,328 men (median 90 [IQR 59-116] days of WCD wear) were included in the final dataset. Among patients who did not receive a shock, over half had insufficient HR control at BOU (59% of women, 53% of men). Although the proportion of patients with resting HR ≥70 beats/min improved by EOU, 43% of women and 36% of men did not achieve guideline-recommended HR control.
Conclusion: A significant proportion of women and men did not achieve adequate HR control during a period of medical therapy optimization. Compared with men, a greater proportion of women receiving WCD shocks had insufficiently controlled HR in the week preceding ventricular tachyarrhythmia/ventricular fibrillation and 43% of nonshocked women, compared with 36% of men, did not reach adequate HR control during the study period. The WCD can be utilized as a remote monitoring tool to record HR and inform adequate uptitration of beta-blockers, with particular focus on reducing the treatment gap in women.
Keywords: Heart rate control; Sudden cardiac death; VF; VT; Ventricular tachyarrhythmia; Wearable cardioverter-defibrillator; Women.
© 2024 Heart Rhythm Society. Published by Elsevier Inc.
Figures



Similar articles
-
High Resting Heart Rates Are Associated with Early Posthospitalization Mortality in Low Ejection Fraction Patients.J Clin Med. 2022 May 20;11(10):2901. doi: 10.3390/jcm11102901. J Clin Med. 2022. PMID: 35629031 Free PMC article.
-
Achieving Guideline-Directed Heart Rate ControlEarly Posthospitalization.Am J Cardiol. 2019 Apr 1;123(7):1096-1100. doi: 10.1016/j.amjcard.2018.12.032. Epub 2019 Jan 4. Am J Cardiol. 2019. PMID: 30683422
-
Use of the Wearable Cardioverter-Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry.J Am Heart Assoc. 2023 Sep 19;12(18):e030615. doi: 10.1161/JAHA.123.030615. Epub 2023 Sep 8. J Am Heart Assoc. 2023. PMID: 37681569 Free PMC article.
-
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.Eur Heart J. 2013 Aug;34(29):2230-42. doi: 10.1093/eurheartj/eht167. Epub 2013 May 31. Eur Heart J. 2013. PMID: 23729691 Review.
-
Value of The Wearable Cardioverter Defibrillator (WCD) as a Bridging-Therapy before Implantation of a Cardioverter Defibrillator (ICD).J Atr Fibrillation. 2016 Feb 29;8(5):1247. doi: 10.4022/jafib.1247. eCollection 2016 Feb-Mar. J Atr Fibrillation. 2016. PMID: 27909469 Free PMC article. Review.
References
-
- Swedberg K., Komajda M., Bohm M., et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376:875–885. - PubMed
-
- Kannel W.B., Kannel C., Paffenbarger R.S., Jr., Cupples L.A. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J. 1987;113:1489–1494. - PubMed
-
- Johansen C.D., Olsen R.H., Pedersen L.R., et al. Resting, night-time, and 24 h heart rate as markers of cardiovascular risk in middle-aged and elderly men and women with no apparent heart disease. Eur Heart J. 2013;34:1732–1739. - PubMed
-
- Hori M., Okamoto H. Heart rate as a target of treatment of chronic heart failure. J Cardiol. 2012;60:86–90. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous